中国医药(600056.SH)：克拉霉素片通过仿制药一致性评价

Core Viewpoint - China Medical (600056.SH) announced that its wholly-owned subsidiary Tianfang Pharmaceutical has received approval from the National Medical Products Administration for the supplemental application of Clarithromycin Tablets, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approval notification for Clarithromycin Tablets was issued by the National Medical Products Administration [1] - The drug has successfully passed the consistency evaluation of quality and efficacy, indicating its compliance with regulatory standards [1]